Clinical Trial Update: A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase II clinical trial update for Roginolisib in advanced/metastatic uveal melanoma; the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Roginolisib (roginolisib)

Snippet

Sponsor: iOnctura | Conditions: Uveal Melanoma, Ocular Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING